Myocarditis
Also known as: Inflammatory myocardial disease, Myocardial inflammation, Viral myocarditis, Immune checkpoint inhibitor-associated myocarditis
Myocarditis is characterized by inflammation of the myocardium, with clinical presentations ranging from subclinical discomfort to malignant arrhythmias, acute heart failure, and cardiogenic shock. Aetiology commonly involves viral infection or immune-mediated responses, including adverse events associated with immune checkpoint inhibitors (ICIs), necessitating immediate biomedical intervention. Acupuncture and Chinese herbal medicine (CHM) are contraindicated in the acute phase; TCM interventions must not delay emergency hospitalisation. Role for TCM is strictly limited to supportive recovery-phase care following medical stabilisation and clearance by a cardiologist. Current literature includes reviews of herbal preparations with low-certainty evidence, which does not validate the efficacy of the specific formulas listed. Evidence supporting acupuncture in myocarditis is absent, and laboratory mechanistic findings are not commensurate with clinical therapeutic benefit.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Strictly adhere to cardiologist-directed restrictions regarding physical exertion and resumption of occupational or athletic activities; avoid strenuous activity to assess recovery status.
- •Maintain a concise clinical diary documenting symptomatology, sleep quality, and tolerance for permitted activities to facilitate medical review.
- •Abstain from alcohol and recreational stimulants throughout the recovery period and pursue smoking cessation support where indicated.
- •Maintain regular nutritional intake and consistent sleep hygiene; prioritize specific fluid and sodium intake parameters prescribed by the cardiologist over general cardiovascular guidelines.
Cautions & Contraindications
- •Suspected active myocarditis, haemodynamic instability or symptomatic arrhythmia precludes elective acupuncture and herbal care; obtain urgent conventional assessment. This is a conservative clinical precaution, not an intervention tested by the supplied reviews.[,]
- •During checkpoint inhibitor-associated myocarditis, do not introduce herbs or alter corticosteroids, cancer therapy or other prescribed treatment without the cardio-oncology team's approval; the supplied review centres management on early recognition and immunosuppression.[]
- •Do not infer formula safety or effectiveness from laboratory pathways, biomarker changes or the low-certainty evidence for other preparations. Product variability and scarce long-term safety data require individual medicine and product review.[]
- •The coronary microvascular acupuncture protocol does not justify needling an acutely symptomatic myocarditis patient or establish myocarditis treatment safety; its findings are not clinical results and its population is different.[]
When to reassess or seek care again
Acute presentations require immediate referral, not a TCM review interval. If recovery-phase support is authorised, review within 1–2 weeks using fatigue and sleep scores from 0–10, appetite, adverse effects and tolerance of medically permitted daily activities. Do not use symptom improvement to infer myocardial healing or permit exercise. Stop adjunctive care and refer for any deterioration; emergency symptoms require 000. If no meaningful supportive benefit after 2–4 weeks, discontinue and reassess with the treating team. Cardiac testing and clearance remain cardiology-led.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Clinical immunology (Orlando, Fla.) · 2026
- Journal of inflammation research · 2026
- Frontiers in cardiovascular medicine · 2026
- Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
- Cochrane Database of Systematic Reviews · 2015
Systematic review supporting PC6 stimulation for postoperative nausea and vomiting.
- JAMA Surgery · 2023
Randomised trial including ST36 for postoperative gastrointestinal recovery.
- Medical Journal of Australia · 2017
Australian emergency-department trial of acupuncture used alongside standard analgesic care.
- World Health Organization · 2008
Standard point locations used for the adjunctive points listed.
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
